I-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023
- Written by PR Newswire
![]() |
ROCKVILLE, Md. and SHANGHAI, Aug. 8, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of pioneering immunotherapies, today announced that it will report business and corporate updates and financial results for the six...















